Скачать или смотреть A Discussion with Brian Finn of Findell Capital: Healthcare Investing, Liquidia & ProQR

An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing.  During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx.  To learn more about Findell Capital please visit their website https://findell.us/

Companies discussed during the podcast;
Liquidia Corporation (Nasdaq: LQDA)
ProQR Therapeutics N.V. (Nasdaq: PRQR)
MiMedx Group Inc (Nasdaq: MDXG)
United Therapeutics Corporation (Nasdaq: UTHR)
MannKind Corporation (Nasdaq: MNKD)
Editas Medicine Inc (Nasdaq: EDIT)

Chapters:

0:00 Introduction
1:52 Findell Capital
6:00 Liquidia Corporation (Nasdaq: LQDA)
30:34 ProQR Therapeutics N.V. (Nasdaq: PRQR)
44:40 Concluding Remarks

NOT FINANCIAL ADVICE

The information is not intended as, and shall not be understood or construed as, financial advice. Neither the Company nor any of its employees or owners shall be held liable or responsible for any errors or omissions on this podcast or for any damage you may suffer as a result of failing to seek competent financial advice from a professional who is familiar with your situation. Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this podcast, expressed or implied herein, are committed at your own risk, financial or otherwise. ​Neither Encode Ideas LP, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever.